At the liver level, GH supplementation drastically improves NASH, reducing the oxidative and inflammatory mediators like the tumour necrosis factor-α (TNFα) and the elevation of acute-phase proteins ((ultrasensitive C Reactive Protein (usPCR)) [24]. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatohepatitis.